Burden of Diabetes in Australia: It's Time for More Action Report

Working with Sydney University and Western Sydney University, Novo Nordisk has launched the Burden of Diabetes in Australia: It's Time for More Action report revealing that diabetes care is falling short for many Australians. 

Find out more here 

Burden of Diabetes in Australia Report

Product Information

Written principally for Healthcare Professionals, the Product Information documents provide prescribing information for each of our products. To access the documents click here

Updated: February 2020

Driving change to defeat diabetes

At Novo Nordisk, we are driven by a core belief: that the alarming rise of diabetes is not inevitable. We can change its trajectory - and we must act now.

Click here to read more

Report a complaint or side effect

Your information about complaints and side effects helps us ensure the safety of our products.

How to report a complaint or side effect  

Medicines Australia Transparency Reports

Please click here to access the reports

We offer 0 job opportunities

For jobs in the United States, please visit our US career site.

Structured approach to ethical business

Each day, Novo Nordisk employees bring ethical standards to work.

Click here to read more

Contact Us

Novo Nordisk Pharmaceuticals Pty Ltd
PO Box 7586
Baulkham Hills BC NSW 2153
ABN 40 002 879 996
Tel: 1800 224 321
Fax: +61 2 8858 3799

Media Enquiries:
Jodie Thomas
Director - Government Relations & Market Access
Tel: +61 0408 200 523
E: jdth@novonordisk.com
HQ Media Relations Contacts

Privacy Officer:

NovoCare® Customer Care Centre:
 1800 668 626
Fax: +61 2 8858 3799

NordiCare® Hotline:
 1800 632 362
Fax: +61 2 8858 3799

Wholesaler Orders - email
Norditropin® Orders - email
Novoseven®RT Orders:
     NBA - email
     Non NBA - email